| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 04/16/2009 | WO2007113650A3 A novel and improved process fro the preparation of nateglinide and its polymorph form-h |
| 04/16/2009 | WO2006041902A3 Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/16/2009 | US20090099366 Process and intermediates for preparing integrase inhibitors |
| 04/16/2009 | US20090098304 Low extractable radiation curable compositions containing aminoacrylates |
| 04/16/2009 | US20090098180 Functionalized amino acids and absorbable polymers therefrom |
| 04/16/2009 | US20090098169 Modified clay mineral |
| 04/16/2009 | US20090098059 Contrast agents |
| 04/16/2009 | US20090098048 Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor |
| 04/16/2009 | CA2702014A1 Method for preparing polymer materials doped with metal elements and resulting materials |
| 04/15/2009 | EP2047828A1 A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container |
| 04/15/2009 | EP2046728A1 Process for preparing pregabalin and its opposite enantiomer |
| 04/15/2009 | EP2046723A2 Phenylacetic acid derivatives as cox-2 inhibitors |
| 04/15/2009 | CN101407472A L-carnitine dodecyl sulphonate, and preparation method and use thereof |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/15/2009 | CN100478358C Dipropyl phthalic acid artificial antigen and its preparation method |
| 04/15/2009 | CN100478329C Alpha-difluoromethyl ornithine (dfmo) intermediate and processes for the production thereof |
| 04/15/2009 | CN100478327C L-dopa methyl ester hydrochloride preparation method |
| 04/15/2009 | CN100478326C Method for preparing aminotrisodium acetate using by product hydrocyanic acid of acrylonitrile device |
| 04/14/2009 | US7517909 Using 3-amino-5-methyl-octanoic acid for therapy of psychiatric, pain and other disorders |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/09/2009 | WO2009046309A2 Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof |
| 04/09/2009 | WO2009045886A1 Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups |
| 04/09/2009 | WO2009044803A1 Process for producing product of asymmetric-catalyst michael reaction |
| 04/09/2009 | WO2009044409A2 Novel resolution process for pregabalin |
| 04/09/2009 | WO2009043444A1 Process for preparing 2-dihaloacyl-3-aminoacrylic acid derivatives |
| 04/09/2009 | WO2009043114A1 Arsenoxide compound and method of use |
| 04/09/2009 | US20090093650 Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylamines |
| 04/09/2009 | US20090093534 Mu opioid receptor ligands: methods of use and synthesis |
| 04/09/2009 | US20090093483 enzyme inhibitor for treating ischemia, anemia, wound healing, auto-transplantation, allo-transplantation, xeno-transplantation, systemic high blood pressure, thalassemia, diabetes, cancer, and inflammatory disorders; N-((4-hydroxy-2-oxo-6-(trifluoromethyl)-2',3',5',6'-tetrahydro-2H-spiro[naphthalene-1,4 |
| 04/09/2009 | DE10346228B4 Herstellung von [18F]fluormarkierten aromatischen L-Aminosäuren Preparation of [18F] fluorine labeled aromatic L-amino acids |
| 04/08/2009 | EP2045235A1 Method for manufacturing (S)-(+)-1,2-diaminopropane-N,N,N',N'-tetra acetic acid tetra esters |
| 04/08/2009 | CN101402585A Method for producing para-aminobenzoic acid with waste and old polystyrene |
| 04/08/2009 | CN101402584A Method for separating and extracting L-glutamic acid from fermentation liquor |
| 04/08/2009 | CN101402583A Levorotation carnitine acid calcium phosphate, preparation method and use thereof |
| 04/08/2009 | CN101402582A Synthesis of alpha-hydroxyl-beta-aminophenol with optical activity |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/07/2009 | US7514578 3-(Di(hetero)arylamino)-2-aroylaminoacrylic acid or ester derivatives, e.g., methyl 2-benzoylamino-3-diphenylaminoacrylate and preparation by replacing a dimethylamino-group with a di(hetero)amino-group; intermediates for IkB kinase inhibitors |
| 04/07/2009 | US7514574 Biodegradable penetration enhancers with multiple hydrophilic moieties |
| 04/07/2009 | US7514555 Compounds for the treatment of metabolic disorders |
| 04/07/2009 | US7514501 Copolymerizable polyalkylene glycol macromonomers, and the preparation and use thereof |
| 04/07/2009 | US7514473 Calcium receptor antagonist; (E)-3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-acrylic acid hydrochloride; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, arthritis, Paget's disease, humoral hypercalcemia, osteoporosis |
| 04/07/2009 | US7514471 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance |
| 04/07/2009 | CA2362833C Phenylalaninol derivatives |
| 04/07/2009 | CA2343962C Process for preparing carboxylic acids |
| 04/02/2009 | WO2009041453A1 Bicyclic γ-amino acid derivative |
| 04/02/2009 | WO2009041385A1 PROCESS FOR PRODUCTION OF α-TYPE GLUTAMIC ACID CRYSTAL |
| 04/02/2009 | WO2009040590A1 Complex product with advanced assimilation efficacy for humans and its utilization |
| 04/02/2009 | US20090088548 Resorbable Phenolic Polymers |
| 04/02/2009 | US20090088475 Indanone derivatives that inhibit prolyl hydroxylase |
| 04/02/2009 | US20090088472 Protective Agent for Neuronal Cell Comprising Amidino Derivative as Active Ingredient |
| 04/02/2009 | US20090087785 Polymerizable composition and planographic printing plate precursor using the same, alkali-soluble polyurethane resin, and process for producing diol compound |
| 04/02/2009 | CA2701110A1 Bicyclic .gamma.-amino acid derivative |
| 04/02/2009 | CA2700727A1 Complex product with advanced assimilation efficacy for humans and its utilization |
| 04/01/2009 | EP2042482A1 Method for manufacturing 2-dihalogenacyl-3-amino-acrylic acid derivatives |
| 04/01/2009 | EP2042478A1 Method for producing -diaryl electron-withdrawing group substituted compound |
| 04/01/2009 | EP2041070A1 Method for producing optically active 3-aminocarboxylic acid esters |
| 04/01/2009 | CN100473642C Preparation method of alpha-alkyl-isoserine and byproduct |
| 04/01/2009 | CN100473637C Rare earth metal compound in aqueous solvent, method for producing the same, and method for producing ceramic powder using the same |
| 03/31/2009 | US7511173 Nutrient, foods; dietary supplements, energy drinks, and dietetic or pharmaceutical products; creatine glycinate |
| 03/31/2009 | US7511167 Emission of high intensity fluorescence in environment of cell membrane; detection hydrophilic, hydrophobic domains |
| 03/31/2009 | US7511156 Analogs of Salinosporamide A |
| 03/31/2009 | US7511153 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof |
| 03/31/2009 | US7511074 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | CA2389749C Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 03/26/2009 | WO2009038204A1 Novel long-chain fatty acid derivative compound and g-protein-coupled receptor agonist containing the compound as active ingredient |
| 03/26/2009 | WO2009037707A2 N-phenyl anthranilic acid derivatives and uses thereof |
| 03/26/2009 | WO2009037345A1 Branched polyesteramine acrylate |
| 03/26/2009 | WO2009037137A2 Process from shikimic acid to oseltamivir phosphate |
| 03/26/2009 | WO2009036898A1 Method for producing 4-aminobut-2-enolides |
| 03/26/2009 | US20090082594 Crystals of l-ornithine and process for producing the same |
| 03/26/2009 | US20090082589 Esters of pentahydroxyhexylcarbamoyl alkanoic acids |
| 03/26/2009 | US20090082540 Hydrolysable linkers and cross-linkers for absorbable polymers |
| 03/26/2009 | US20090082452 Deuterium-enriched lumiracoxib |
| 03/26/2009 | US20090082450 Deuterium-enriched diclofenac |
| 03/26/2009 | US20090080074 Polymer film, polarizing plate protective film, polarizing plate and liquid crystal display device |
| 03/26/2009 | CA2699580A1 Process from shikimic acid to oseltamivir phosphate |
| 03/25/2009 | EP2039678A1 Method for manufacturing 4-aminobut-2-enolids |
| 03/25/2009 | EP2038249A1 Process for preparing gabapentin |
| 03/25/2009 | EP1841725B1 A process for the purification of gabapentin |
| 03/25/2009 | CN101395165A Ligand, method for producing the same, and catalyst using the ligand |
| 03/25/2009 | CN101391966A Method for preparing stereoselectivity of complete protected 2-amido-6-hydroxyl-4-methyl-8-carbonyl capric acid |
| 03/25/2009 | CN100471833C Process for preparing aspartates |
| 03/24/2009 | US7507859 Quaternary ammonium compound having ester and/or amide groups; cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids |
| 03/24/2009 | CA2176373C Farnesyl derivatives and pharmaceutical compositions containing them |
| 03/19/2009 | WO2009034258A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
| 03/19/2009 | WO2009009287A3 Hormone sensitive lipase modulators and methods of use |
| 03/19/2009 | WO2009007827A3 Novel diclofenac esters and uses thereof |
| 03/19/2009 | WO2008137512A3 Process for preparing pregabalin via hofmann reaction and crystalline form thereof |
| 03/19/2009 | WO2008118494A3 Fluoroalkyl surfactants |
| 03/19/2009 | US20090076301 Methods for producing nateglinide crystals |
| 03/19/2009 | US20090076296 Reacting alkyl (3R,4S,5R) 3,4,5-trihydroxy-1-cyclohexene-1-carboxylate with methanesulfonyl chloride, reaction with sodium azide in presence of phase transfer catalyst is tetrabutylammonium hydrogen sulfate, reaction with triethylphosphite, reacting with alcohol solvent and a Lewis acid |
| 03/19/2009 | US20090076150 Deuterium-enriched bromfenac |
| 03/19/2009 | US20090076145 Deuterium-enriched amibegron |
| 03/19/2009 | US20090076113 Biphenylcarboxamides for controlling micro-organisms |
| 03/19/2009 | US20090076110 An amine salt of nitric acid and aginine, beta alanine, agmatine, citrulline, creatine, glutamine, L-histidine, isoleucine, leucine,norvaline, or ornithine; vasodilation; metabolism of mucle protein;exercise |
| 03/19/2009 | US20090074691 Topical Delivery System for Antiaging and Skin Whitening Agents |
| 03/19/2009 | CA2692702A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
| 03/18/2009 | EP2035566A2 Materials and complexes for the delivery of biologically-active material to cells |